関連する概念動画
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations.
American journal of respiratory and critical care medicine·2026
Same author
Imbalanced immune cell network and suboptimal cell activation: signatures associated with disease severity in vaccine-naïve COVID-19 patients.
Frontiers in immunology·2026
Same author
Age, sex, smoking-specific prevalence and progression in interstitial lung abnormality: patient-level meta-analysis.
Annals of the American Thoracic Society·2026
関連する実験動画
Updated: May 31, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
イディオパシー性肺線維症とは
Talmadge E King1, Annie Pardo, Moisés Selman
1Department of Medicine, University of California, San Francisco, CA 94143-0120, USA. tking@medicine.ucsf.edu
Lancet (London, England)
|July 2, 2011
まとめ
Idiopathic pulmonary fibrosis (IPF) は,年齢に関係する肺疾患である. 現在の証拠は,異常に活性化されたアルベオラ上皮細胞が線維症を誘発し,肺の傷痕と破壊につながることを示唆しています.
科学分野:
- 肺内科 肺内科 肺内科
- 肺疾患の病原性について
- 年齢に関係する病気
背景:
- Idiopathic pulmonary fibrosis (IPF) は,治療法が限られている重症で,年齢に関係する肺疾患です.
- 以前は炎症性と考えられていたIPFの病原性は,活性化アルベオラ上皮細胞 (AEC) と関連付けられている.
- AECは,フィブロブラスト/ミオフィブロブラストの焦点形成を促進するメディエーターを生成することによって,線維症を駆動する.
研究 の 目的:
- IPFに関する現在の理解をレビューする.
- IPFの臨床経過と治療選択肢について議論する.
- 老化と上皮細胞の活性化を含む,IPFの病原性に基づくメカニズムを探求する.
主な方法:
- IPFに関する最近のデータに関する文献レビュー.
- 老化,表遺伝的変化,および異常な表皮細胞活性化とIPFを結びつける証拠の分析.
- 臨床的側面と治療戦略に関する情報の統合.
主要な成果:
- IPFにおける線維症は,線維芽細胞とミオフィブロブラストの焦点による細胞外マトリックス,主にコラーゲンの過剰な堆積によるものです.
- 発達経路の異常な復元と表遺伝的変異は,IPFの病原性に関与しています.
結論:
- IPFの病原化には,老化,異常な上皮細胞活性化,および線維性プロセスとの複雑な相互作用が含まれています.
- これらのメカニズムを理解することは,IPFの効果的な治療戦略の開発に不可欠です.
- IPFを誘発する分子経路を明らかにし,新しい治療目標を特定するために,さらなる研究が必要である.